𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The use of L-DOPA in Parkinson's disease: a 20 year follow-up

✍ Scribed by André Barbeau


Book ID
119110700
Publisher
Elsevier Science
Year
1981
Tongue
English
Weight
474 KB
Volume
2
Category
Article
ISSN
0165-6147

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Mortality in Parkinson's disease: A 20-y
✍ Anja Diem-Zangerl; Klaus Seppi; Gregor K. Wenning; Eugen Trinka; Gerhard Ransmay 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

## Abstract We determined mortality rates and predictors of survival in 238 consecutive patients with Parkinson's disease (PD) with symptom onset between 1974 and 1984. All patients were regularly followed at the Movement Disorder Clinic (Department of Neurology at the Innsbruck Medical University)

Fatigue in Parkinson's disease: a nine-y
✍ J.H. Friedman; H. Friedman 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 21 KB 👁 1 views

## Abstract Fatigue affects about 50% of Parkinson's disease (PD) patients and is frequently one of its most disabling aspects. It does not correlate with disease severity or duration but does correlate with depression. Fatigue and depression are distinct symptoms and fatigue often fails to respond

Striatal subregional 6-[18F]fluoro-L-dop
✍ Anna Brück; Sargo Aalto; Elina Nurmi; Tero Vahlberg; Jörgen Bergman; Juha O. Rin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

## Abstract Thirty‐one drug‐naive patients with Parkinson's disease (PD) underwent 6‐[^18^F]fluoro‐L‐dopa (F‐dopa) positron emission tomography (PET) scan at the time of the diagnosis (baseline) and 2 years later in order to investigate F‐dopa uptake in striatal and extrastriatal regions during the